Ind-Ra assigns/affirms IND AA ratings to Eris Lifesciences’ subsidiary Eris Therapeutics’ bank facilities with Stable outlook, citing strong parent support, robust EBITDA growth, and diversified product portfolio.
AI Assistant
ERIS Lifesciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.